Blackheads, whiteheads, papules, and pustules on the face, neck, back, and chest are all symptoms of acne vulgaris, a common skin disorder. It is most typically seen in adolescents, but it can also affect adults. Acne can be classified as mild, moderate, or severe depending on its severity. It is caused by the overproduction of oil in the sebaceous glands beneath the skin, which get clogged and swollen. Acne can affect female patients with polycystic ovarian syndrome, as well as hormonal abnormalities such as excess androgen production. Social disengagement, low self-esteem, and depression with suicidal impulses are common symptoms of acne vulgaris.
Over the projection period, the United States is predicted to be the largest market for acne vulgaris treatment products.
According to a study published in the British Journal of Dermatology in 2015, Acne Vulgaris Treatment Market affects 9.4 percent of the global population. Acne is also the eighth most common disease on the planet. The greatest market for acne vulgaris treatment solutions is the United States. According to research conducted by the National Institute of Health (NIH), over $3 billion was spent in the United States in 2013 to treat acne vulgaris. According to the American Academy of Dermatology, the number of acne vulgaris patients aged 25 and over, particularly women, is on the rise in 2014. Another factor contributing to the rising prevalence of acne vulgaris is a lack of knowledge about the causes of acne.
Market Taxonomy for Acne Vulgaris Treatment:
The global acne vulgaris treatment market is divided into three categories based on product type:
Medications
Peroxides of benzoyl
Retinoids
Antibiotics, both systemic and topical
Hormonal Substances
Others are (Salicylic Acid, Azelaic, Dapsone, and Alternative therapy)
Devices
Devices that use lasers
Devices that remove heat
Others
By 2020, India is predicted to have the largest population pool in the 15–25 age bracket. As a result, the market for acne vulgaris treatment treatments is extremely lucrative. India's diet has a high glycemic index, which is projected to help the market growth throughout the forecast period. Manufacturers are also concentrating on producing treatments to treat acne scars. For the treatment of scarring, new treatments like as cosmetic (laser, chemical peel, and photodynamic therapy) and surgical procedures are being developed. Another factor projected to contribute to the expansion of the acne vulgaris treatment market is increasing consumer inclination towards alternative ways to treat acne vulgaris, such as herbal therapy (tee tree oil), due to reduced side effects. Acne removal devices that can be used at home.
Allergan plc, GlaxoSmithKline plc, Valeant Pharmaceutical International Inc., F.Hoffmann-La Roche AG, Mylan, N.V., Bayer AG, Janssen Pharma Inc., Galderma Inc., Pfizer Inc., and Novan Inc. are key competitors in the global acne vulgaris treatment market.
0 Comments